Prosthesis With Sensations
Restoration of Sensations From the Lost Limb to Amputees for Fall Avoidance, Regular Walking, Phantom Limb Pain Diminishment and Embodiment of Prosthesis
1 other identifier
interventional
3
1 country
1
Brief Summary
Lower limb amputees suffer complete lack of sensory feedback of current available prostheses, which excludes the central nervous system from the correct sensory-motor integration. It causes serious problems as: falls due to unexpected perturbations, asymmetric walking, low mobility, higher power consumption, feeling the prosthesis as a foreign body, high cognitive burden, and phantom limb pain occurrence. Investigators will provide amputees with a prosthesis restoring sensory feedback and will assess its benefits on the users.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 12, 2017
CompletedStudy Start
First participant enrolled
November 12, 2017
CompletedFirst Posted
Study publicly available on registry
November 22, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 14, 2020
CompletedJuly 15, 2020
July 1, 2020
9 months
November 12, 2017
July 14, 2020
Conditions
Outcome Measures
Primary Outcomes (4)
Impact of SENSY on mobility
Demonstration of statistically relevant increase of kinematic walking speed (distance/minute) during the execution of tests involving the use of the prosthesis with intraneural stimulation compared to without the stimulation (e.g. climbing and descending stairs, tandem walking, walking on an outdoor surface).
within 3 months post implant
Impact of SENSY on falls avoidance
Demonstration of statistically relevant decrease of falls during the execution of tests involving the use of the prosthesis with intraneural stimulation compared to without the stimulation (e.g. walking on a surface with obstacles).
within 3 months post implant
Impact of SENSY on metabolic consumption
Demonstration of statistically relevant decrease of metabolic cost during the execution of tests involving the use of the prosthesis with intraneural stimulation compared to without the stimulation (e.g. walking on the treadmill and walking on an outdoor surface). Metabolic cost is measured as volume of oxygen (VO2) consumption (mLO2/kg/meter).
within 3 months post implant
Incidence of all serious adverse events concerning SENSY
Incidence of all serious adverse events, including Serious Adverse Events, Serious Adverse Device Events, and Unanticipated (Serious) Adverse Device Events from the time of consent through 3 months post implant.
within 3 months post implant
Secondary Outcomes (8)
Impact of SENSY on phantom pain: neuropathic pain symptom inventory score
within 3 months post implant
Impact of SENSY on phantom pain: visual analog scale score
within 3 months post implant
Impact of SENSY on phantom pain before and after the implant of SENSY: NPSI score
until up to 3 months post explant
Impact of SENSY on phantom pain before and after the implant of SENSY: VAS score
until up to 3 months post explant
Impact of SENSY on embodiment (perception of the prosthesis as part of the body): questionnaires
within 3 months post implant
- +3 more secondary outcomes
Study Arms (1)
SENSY benefit
EXPERIMENTALSensory feedback elicited by intraneural stimulation will be provided by SENSY with and without the leg prosthesis to improve walking ability, increase embodiment, and reduce metabolic cost, cognitive load and phantom pain.
Interventions
The sensory feedback will be delivered by SENSY with or without the leg prosthesis. Benefits connected to the stimulation of sensory nerves will be assessed.
Eligibility Criteria
You may qualify if:
- Uni-lateral transfemoral amputation above the knee level
- Other treatments for phantom limb pain should have been tried with poor results
- The subject should experience phantom limb pain at a level of 6 or higher measured on on a visual analog scale (VAS) ranging from 0-10
- Phantom limb pain should be experienced at least once a week
- The subject should be in a chronic and stable phase, and the stump should have healed
- The subject should otherwise be healthy and able to carry out the experiment
- If pain medication is used it will be acceptable that the person continues to use the medication
You may not qualify if:
- Cognitive impairment
- Pregnancy
- Prior or current psychological diseases such as borderline, schizophrenia, depression or maniodepression
- Acquired brain injury with residual impairment
- Prior neurological or musculoskeletal diseases
- History of or active substance abuse disorder
- Excessive sensitivity to electrical stimulation with surface electrodes
- Persons with fear for electrical stimulation, pain cannot participate
- Persons that are hypersensitive to electrical stimulation and experience the stimulation as unpleasant cannot participate
- Since the protocol includes MRI scanning of the brain, persons that may feel claustrophobic cannot participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Clinical Centre of Serbialead
- Axoniccollaborator
- SensArs Neuroprosthetics Sarlcollaborator
- Institut für Mikrosystemtechnik (IMTEK), Albert-Ludwigs-Universität Freiburgcollaborator
- Ripple LLCcollaborator
- Össur hfcollaborator
Study Sites (1)
Clinical center of Serbia
Belgrade, RS, 11000, Serbia
Related Publications (4)
Valle G, Katic Secerovic N, Eggemann D, Gorskii O, Pavlova N, Petrini FM, Cvancara P, Stieglitz T, Musienko P, Bumbasirevic M, Raspopovic S. Biomimetic computer-to-brain communication enhancing naturalistic touch sensations via peripheral nerve stimulation. Nat Commun. 2024 Feb 20;15(1):1151. doi: 10.1038/s41467-024-45190-6.
PMID: 38378671DERIVEDPetrusic I, Valle G, Dakovic M, Damjanovic D, Bumbasirevic M, Raspopovic S. Plastic changes in the brain after a neuro-prosthetic leg use. Clin Neurophysiol. 2022 Jun;138:186-188. doi: 10.1016/j.clinph.2022.04.001. Epub 2022 Apr 9. No abstract available.
PMID: 35461007DERIVEDPreatoni G, Valle G, Petrini FM, Raspopovic S. Lightening the Perceived Prosthesis Weight with Neural Embodiment Promoted by Sensory Feedback. Curr Biol. 2021 Mar 8;31(5):1065-1071.e4. doi: 10.1016/j.cub.2020.11.069. Epub 2021 Jan 7.
PMID: 33417885DERIVEDPetrini FM, Bumbasirevic M, Valle G, Ilic V, Mijovic P, Cvancara P, Barberi F, Katic N, Bortolotti D, Andreu D, Lechler K, Lesic A, Mazic S, Mijovic B, Guiraud D, Stieglitz T, Alexandersson A, Micera S, Raspopovic S. Sensory feedback restoration in leg amputees improves walking speed, metabolic cost and phantom pain. Nat Med. 2019 Sep;25(9):1356-1363. doi: 10.1038/s41591-019-0567-3. Epub 2019 Sep 9.
PMID: 31501600DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Aleksandar Lešić, Prof
Clinical center of Serbia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- President
Study Record Dates
First Submitted
November 12, 2017
First Posted
November 22, 2017
Study Start
November 12, 2017
Primary Completion
August 1, 2018
Study Completion
July 14, 2020
Last Updated
July 15, 2020
Record last verified: 2020-07